-
Dr. Jia Wang & Dr. William Gradishar: Controversies in Surgical Treatment for Stage IV Breast Cancer Patients at Initial Diagnosis
There is currently a lack of consensus on whether surgical treatment should be performed for patients with stage IV breast cancer at the initial diagnosis. At the 18th St.Gallen Breast Cancer Conference (SGBCC 2023), a debate titled “Surgery of the primary for stage IV disease” garnered global expert attention. The debate was moderated by Dr.…
-
Oncology Frontier interviewed professor Silvia Stacchiotti on-site at ESMO.
Based on your extensive research and practical experience in the field of sarcoma, could you provide insights into the current advancements and challenges in treating patients with metastatic sarcoma?
-
Dr. Nigel Russell: The Latest International Treatment Advances in Acute Myeloid Leukemia
Abstract: Dr. Nigel Russell provides insights into the recent developments in the treatment landscape of Acute Myeloid Leukemia (AML). The discussion encompasses the combination of FLT3 mutation inhibitors with intensive…
-
Navigating Prostate Cancer with Precision: Next-Generation Imaging Insights from Professor Silke Gillessen
Embarking on the frontier of prostate cancer research, Professor Silke Gillessen shares her expertise in an exclusive interview with Oncology Frontier at the European Society for Medical Oncology (ESMO). In…
-
Discovery and Verification of HBV Auxiliary Receptor NRP1
Hepatitis B Virus (HBV) infection is one of the main causes of liver diseases, affecting approximately 292 million people worldwide who are chronic carriers of HBV, leading to severe conditions like liver cirrhosis and primary liver cancer. The infection process of HBV relies on the binding of the viral envelope proteins to receptors on the…
-
The Cure Puzzle: Key Factors in Curing Metastatic Sarcoma Explored with Professor Silvia Stacchiotti
Engaging in a critical discussion on the topic of “When can we cure patients with metastatic sarcoma?” Professor Silvia Stacchiotti provided invaluable insights during an exclusive interview with Oncology Frontier…
-
Revolutionizing Cancer Treatment: Unveiling TAR-200 with Professor Andrea Nccchi
In a captivating interview conducted on-site at the European Society for Medical Oncology (ESMO), Oncology Frontier had the privilege of engaging with Professor Andrea Nccchi to unravel the mysteries behind…
-
Prostate Cancer: Unveiling the Roles of Germline and Tumor Testing with Professor Kim Nguyen N. Chi
Delving into the intricate landscape of prostate cancer diagnostics, understanding the roles of germline testing and tumor testing is paramount. At the prestigious ESMO Congress 2023, Oncology Frontier had the…
Connecting Medical Expertise through Media